Tim McCourt has served as CME Group’s Senior Managing Director, Global Head of Financial and OTC Products since June 2023. He is responsible for leading the development and execution of the company’s global interest rate, equity index, foreign exchange, OTC, cryptocurrency and alternative investment product strategies. Previously, he served as Senior Managing Director, Global Head of Equity and Foreign Exchange Products since February 2022. He serves on the CME Ventures Investment Committee and the S&P Dow Jones Indices U.S. Advisory Panel. 

Before joining CME Group in 2013 as Global Head of Equity Products, McCourt worked for the Royal Bank of Scotland, where he was responsible for building and managing the Americas Index and Delta One trading book. Prior to RBS, he held a senior trading role with JPMorgan in New York, spending 10 years with the Equity Derivatives Group. 

McCourt holds a bachelor’s degree in political science from Boston College and an MBA from The University of Pennsylvania’s Wharton School

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.